<?xml version="1.0" encoding="UTF-8"?><TimeML><TIMEX3 tid="t0" functionInDocument="CREATION_TIME"/>Japan's Takeda Chemical Industrial Co. Ltd. <EVENT eid="e1" class="REPORTING" tense="PAST" aspect="NONE" polarity="POS" modality="none">said</EVENT>  <TIMEX3 tid="t1" type="DATE">Wednesday</TIMEX3> its pre-tax earnings <EVENT eid="e2" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">slipped</EVENT> 0.4 percent to 77.2 billion yen (750  million dollars) in <TIMEX3 tid="t2" type="DATE">the year</TIMEX3> to <TIMEX3 tid="t3" type="DATE">March</TIMEX3> and <EVENT eid="e3" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">forecast</EVENT> a further <EVENT eid="e4" class="OCCURRENCE" tense="NONE" aspect="NONE" polarity="POS" modality="none">decline</EVENT> <TIMEX3 tid="t4" type="DATE">this year</TIMEX3>.&#13;
The country's biggest drugmaker <EVENT eid="e5" class="REPORTING" tense="PAST" aspect="NONE" polarity="POS" modality="none">said</EVENT> sales <EVENT eid="e6" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">fell</EVENT> 0.6 percent from <TIMEX3 tid="t5" type="DATE">a year  earlier</TIMEX3> to 562 billion yen. Increased revenue from pharmaceuticals,  agrochemicals and veterinary drugs was <EVENT eid="e7" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">offset</EVENT> by lower revenue from  healthcare, food and vitamins, and chemicals.&#13;
Takeda <EVENT eid="e8" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">projected</EVENT> a smaller profit of 72 billion yen for <TIMEX3 tid="t6" type="DATE">the current year</TIMEX3>  despite an improved sales forecast of 585 billion.&#13;
"The business environment in the pharmaceutical industry has <EVENT eid="e9" class="ASPECTUAL" tense="PRESENT" aspect="PERFECTIVE" polarity="POS" modality="none">entered</EVENT> an  extremely severe phase, as <EVENT eid="e10" class="OCCURRENCE" tense="PRESENT" aspect="NONE" polarity="POS" modality="none">shown</EVENT> by the revision of drug pricing standards in  <TIMEX3 tid="t7" type="DATE">April</TIMEX3> and government policies to <EVENT eid="e11" class="OCCURRENCE" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="none">restrain</EVENT> medical expenses," the company <EVENT eid="e12" class="REPORTING" tense="PAST" aspect="NONE" polarity="POS" modality="none">said</EVENT>.&#13;
In <TIMEX3 tid="t8" type="DATE">the year just</TIMEX3> ended, drug sales <EVENT eid="e13" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">grew</EVENT> 0.9 percent to 324 billion yen,  sales of agrochemicals and veterinary drugs <EVENT eid="e14" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">climbed</EVENT> 8.7 percent to 47 billion  yen and sales of environmental products <EVENT eid="e15" class="OCCURRENCE" tense="PRESENT" aspect="NONE" polarity="POS" modality="none">rose</EVENT> 6.7 percent to nine billion yen.&#13;
But sales of healthcare products <EVENT eid="e16" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">dropped</EVENT> 4.5 percent to 51 billion yen,  sales of food and vitamins <EVENT eid="e17" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">declined</EVENT> 5.9 percent to 62 billion yen and chemical  sales <EVENT eid="e18" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">fell</EVENT> 5.9 percent to 68 billion yen. Exports were down 0.5 percent at 59  billion yen, the company <EVENT eid="e19" class="REPORTING" tense="PAST" aspect="NONE" polarity="POS" modality="none">said</EVENT>.&#13;
<TLINK relType="BEFORE" eventID="e1" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e3" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e5" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e7" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e9" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e12" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e14" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e17" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e19" relatedToTime="t0"/><TLINK relType="IS_INCLUDED" eventID="e2" relatedToTime="t1"/><TLINK relType="IS_INCLUDED" eventID="e2" relatedToTime="t3"/><TLINK relType="IS_INCLUDED" eventID="e3" relatedToTime="t1"/><TLINK relType="IS_INCLUDED" eventID="e3" relatedToTime="t3"/><TLINK relType="IS_INCLUDED" eventID="e4" relatedToTime="t1"/><TLINK relType="IS_INCLUDED" eventID="e4" relatedToTime="t3"/><TLINK relType="IS_INCLUDED" eventID="e8" relatedToTime="t6"/><TLINK relType="IS_INCLUDED" eventID="e10" relatedToTime="t7"/><TLINK relType="IS_INCLUDED" eventID="e12" relatedToTime="t7"/><TLINK relType="IS_INCLUDED" eventID="e14" relatedToTime="t8"/><TLINK relType="AFTER" eventID="e5" relatedToEvent="e6"/><TLINK relType="BEFORE" eventID="e10" relatedToEvent="e11"/><TLINK relType="IS_INCLUDED" eventID="e15" relatedToTime="t8"/><TLINK relType="IS_INCLUDED" eventID="e13" relatedToTime="t8"/><TLINK relType="IS_INCLUDED" eventID="e11" relatedToTime="t7"/><TLINK relType="IS_INCLUDED" eventID="e9" relatedToTime="t7"/><TLINK relType="IS_INCLUDED" eventID="e4" relatedToTime="t4"/><TLINK relType="IS_INCLUDED" eventID="e4" relatedToTime="t2"/><TLINK relType="IS_INCLUDED" eventID="e3" relatedToTime="t4"/><TLINK relType="IS_INCLUDED" eventID="e3" relatedToTime="t2"/><TLINK relType="IS_INCLUDED" eventID="e2" relatedToTime="t4"/><TLINK relType="IS_INCLUDED" eventID="e2" relatedToTime="t2"/><TLINK relType="IS_INCLUDED" eventID="e1" relatedToTime="t1"/><TLINK relType="BEFORE" eventID="e18" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e16" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e13" relatedToTime="t0"/><TLINK relType="AFTER" eventID="e11" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e8" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e6" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e4" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e2" relatedToTime="t0"/></TimeML>